Early versus delayed angiotensin-converting enzyme inhibition in experimental chronic heart failure: Effects on survival, hemodynamics, and cardiovascular remodeling

Circulation

Volumn 95, Issue 5, 1997, Pages 1314-1319

  Mulder, Paul ^a   Devaux, Bruno ^a   Richard, Vincent ^a   Henry, Jean Paul ^a   Wimart, Marie Catherine ^a   Thibout, Emmanuel ^a   Macé, Bertrand ^a   Thuillez, Christian ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

angiotensin; heart failure; hypertrophy; pharmacology

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HEART FAILURE; HEART HEMODYNAMICS; HEART VENTRICLE REMODELING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RAT; TREATMENT OUTCOME;

EID: 0031025632     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.5.1314     Document Type: Article

References (21)

1. CONSENSUS Trial Study. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
2. Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
3. SAVE. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327:669-677.
4. Trandolapril Cardiac Evaluation (TRACE) Study. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670-1676.
5. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circ Res. 1985;72:406-412.
6. SOLVD. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293-302.
7. Thuillez C, Richard C, Loueslati H, Auzepy P, Giudicelli JF. Systemic and regional hemodynamic effects of perindopril in congestive heart failure. J Cardiovasc Pharmacol. 1990;15:527-535.
8. Richer C, Mulder P, Fernes P, Domergue V, Heudes D, Giudicelli JF. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival myocardial infarction in rats. J Cardiovasc Pharmacol. 1992;20:147-156.
9. Wollert KC, Studer R, Just H, Drexler H. Influence of lisinopril on long-term mortality in rats with chronic myocardial infarction: role of blood pressure reduction and tissue ACE inhibition. Circulation. 1994;90:2457-2467.
10. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue specific activation of the cardiac angiotensin converting enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
11. Michel JB, Heudes D, Michel O, Poitevin P, Phillippe M, Scalbert E, Corman B, Levy B. Effect of chronic ANG I-converting enzyme inhibition on aging processes, II: large arteries. Am J Physiol. 1994;267:R124-R135.
12. Mulder P, Elfertak L, Richard V, Compagnon P, Devaux B, Henry JP, Scalbert E, Desché P, Macé B, Thuillez C. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol. 1996;271:H469-H477.
13. Gaudron P, Kugler I, Hu K, Eilles C, Ertl G. Quinapril, initiated after advanced ventricular dilation in patients with chronic infarction, prevents progressive remodeling. J Am Coll Cardiol. 1996;27:228A. Abstract.
14. Halpern W, Kelley M. In vitro methodology for resistance arteries. Blood Vessels. 1991;28:245-251.
15. Dohi Y, Thiel MA, Bühler FR, Lüscher TF. Activation of endothelial L-arginine pathway in resistance arteries: effect of age and hypertension. Hypertension. 1990;15:170-179.
16. Weber KT, Janicki JS, Schroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied non-human primate myocardium. Circ Res. 1988;62:757-765.
17. Nicoletti A, Heudes D, Hinglais N, Appay M-D, Philippe M, Sassy-Prigent C, Bariety J, Michel J-B. Left ventricular fibrosis in renovascular hypertensive rats: effect of losartan and spironolactone. Hypertension. 1995;26:101-111.
18. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58:690-700.
19. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat Circ Res. 1985;57:84-95.
20. Gay RG. Early and late effects of captopril treatment after large myocardial infarction in rats. J Am Coll Cardiol. 1990;16:967-977.
21. Heeneman S, Leenders PJA, Aarts PJJW, Smits JFM, Arends JW, Daemen MJAP. Peripheral vascular alterations during experimental heart failure in the rat: do they exist? Arterioscler Thromb Vasc Biol. 1995;15:1503-1511.